Overall Investment Decision Making
Focus for Round 2
The role of QGHA is to maximise the benefits presented by genomic medicine and more broadly precision medicine. QGHA brings together healthcare systems’ innovation and advancing medical and social research, with the aim of accelerating the adoption of applicable medical genomics into mainstream healthcare.
The QGHA is focused on its eight Core Objectives within four outcome themes:
Patients and Community
Clinicians and Clinical Practice
In Round 2, QGHA moves from its initial research, demonstration and ‘discovery’ orientation to a focus on patient outcomes through:
Sustainable clinical genomics implementation and incubation;
Clinical innovation to match future needs; and
Targeted health system capability-building.
The following principles for Round 2 investment and decision making have been approved by Queensland Health.